Cabozantinib for treating advanced neuroendocrine tumours that have progressed after systemic treatment [ID6474]

  • In development
  • GID-TA11613
  • Expected publication date: 

Register as a stakeholder

Documents

Documents created during the development process.

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6474

Referral